BCLI

Brainstorm Cell Therapeu... Stock Price

10.71
0.525 (5.15%)
Upgrade to Real-Time
Afterhours (Closed)
10.71
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Brainstorm Cell Therapeutics Inc BCLI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.525 5.15% 10.71 00:00:05
Close Price Low Price High Price Open Price Previous Close
10.75 10.20 10.90 10.24 10.185
Bid Price Ask Price Spread News
4.00 20.00 16.00 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
5,220 722,804 $ 10.60 $ 7,660,968 728,748 3.36 - 17.95
Last Trade Time Type Quantity Stock Price Currency
19:45:56 10 $ 10.90 USD

Brainstorm Cell Therapeu... Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 338.09M 31.57M 26.70M $ - $ - -1.06 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 117.96k 7.40%

more financials information »

Brainstorm Cell Therapeu... News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BCLI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week15.3115.44998.7110.562,416,779-4.60-30.05%
1 Month14.1517.958.7112.90968,949-3.44-24.31%
3 Months14.0717.958.7113.05587,359-3.36-23.88%
6 Months6.1617.955.0511.71645,0014.5573.86%
1 Year3.8817.953.369.29541,7546.83176.03%
3 Years4.2817.952.888.07238,8846.43150.23%
5 Years2.7317.951.906.79196,1437.98292.31%

Brainstorm Cell Therapeu... Description

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.